Login / Signup
María Cristina Trejo-Solís
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Adverse Drug
Cancer Stem Cells
Squamous Cell
Resting State
Top Venues
Medical oncology (Northwood, London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Juan Carlos Gallardo-Pérez
,
María Cristina Trejo-Solís
,
Diana Xochiquetzal Robledo-Cadena
,
Rebeca López-Marure
,
Lourdes Teresa Agredano-Moreno
,
Luis Felipe Jiménez-Garcia
,
Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma.
Medical oncology (Northwood, London, England)
40 (3) (2023)
Juan Carlos Gallardo-Pérez
,
María Cristina Trejo-Solís
,
Diana Xochiquetzal Robledo-Cadena
,
Rebeca López-Marure
,
Lourdes Teresa Agredano-Moreno
,
Luis Felipe Jiménez-Garcia
,
Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma.
Medical oncology (Northwood, London, England)
40 (3) (2023)
Juan Carlos Gallardo-Pérez
,
María Cristina Trejo-Solís
,
Diana Xochiquetzal Robledo-Cadena
,
Rebeca López-Marure
,
Lourdes Teresa Agredano-Moreno
,
Luis Felipe Jiménez-Garcia
,
Laura Gabriela Sánchez-Lozada
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma.
Medical oncology (Northwood, London, England)
40 (3) (2023)